Dr. Martens (LON:DOCS) Trading Down 9.6% – Here’s Why

Dr. Martens plc (LON:DOCS) shares were down 9.6% on Friday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. Approximately 4,733,644 shares changed hands during trading, an increase of 115% from the average daily volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Analyst Upgrades and Downgrades

Separately, Peel Hunt reiterated a “buy” rating on shares of Dr. Martens in a research note on Thursday. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of GBX 6,000.

Dr. Martens Stock Down 0.7%

The firm has a 50-day moving average of GBX 89.93 and a two-hundred day moving average of GBX 80.61. The firm has a market cap of £707.84 million, a price-to-earnings ratio of 146.50, a PEG ratio of 6.40 and a beta of 0.11. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS) last issued its quarterly earnings results on Thursday, November 20th. The company reported GBX (0.90) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, sell-side analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.

Insider Buying and Selling at Dr. Martens

In other Dr. Martens news, insider Ije Nwokori sold 298,675 shares of the stock in a transaction on Wednesday, October 15th. The shares were sold at an average price of GBX 90, for a total value of £268,807.50. Also, insider Giles Wilson purchased 105,838 shares of the firm’s stock in a transaction on Monday, September 1st. The stock was bought at an average price of GBX 91 per share, for a total transaction of £96,312.58. Over the last quarter, insiders have purchased 136,960 shares of company stock valued at $12,460,163 and have sold 434,460 shares valued at $39,131,400. 2.80% of the stock is owned by corporate insiders.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.